Provenance du réseau au premier degré de Laurent Cassedannemr
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
11
| Public Company | Pharmaceuticals: Generic | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Laurent Cassedannemr via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor Private Equity Analyst | |
HRA Pharma Development SARL
 HRA Pharma Development SARL Pharmaceuticals: MajorHealth Technology HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
ADEMTECH SA
 ADEMTECH SA Miscellaneous Commercial ServicesCommercial Services ADEMTECH SA specializes in developing and manufacturing magnetic nanoparticles for diagnostic and scientific research applications. The firm produces magnetic nanoparticles for concentration, separation, purification, microfluidic device integration and identification of molecules and specific cells. The company was founded in 2000 and is headquartered in Pessac, France. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
GamaMabs Pharma SA
 GamaMabs Pharma SA Medical/Nursing ServicesHealth Services GamaMabs Pharma SA specializes in developing monoclonal antibodies. It offers research and development solutions for biopharmaceutical industry. The company was founded by Jean-Francois Prost and Stephane Degove in June 2013 and is headquartered in Toulouse, France. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
CorWave SA
 CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director/Board Member | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Cemag SAS
 Cemag SAS Miscellaneous Commercial ServicesCommercial Services Cemag SAS is a French company that specializes in research and development of physical and natural sciences. The private company is based in Paris, France. | Miscellaneous Commercial Services | Chairman | |
| Cemag Consulting | Chief Executive Officer | ||
| University of Paris Jussieu | College/University | Doctorate Degree | |
| Cemag-Care SA | Founder | ||
| Physip SA | Director/Board Member | ||
| AMERICAN PACIFIC CORPORATION | Chemicals: Major Diversified | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Laboratoire HRA-Pharma SA
 Laboratoire HRA-Pharma SA Pharmaceuticals: MajorHealth Technology Laboratoire HRA Pharma SA manufactures and distributes pharmaceutical products. Its products include contraceptive pills such as the pill of two days later and EllaOne. The company was founded by Andre Ulmann in 1996 and is headquartered in Paris, France. | Pharmaceuticals: Major | Founder | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Executive Officer | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
Sibley & Associates, Inc.
 Sibley & Associates, Inc. Services to the Health IndustryHealth Services Whether its clients are an insurer, employer, or government organization, Sibley is their best connection to a single source solution to their disability issues. Through connected thinking, it provides fully-integrated solutions to prevent, manage and resolve client injury or illness no matter where their disability issues fall along the healthcare continuum. The company put all the pieces together. | Services to the Health Industry | President | |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer | |
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
| AKARI THERAPEUTICS, PLC | Biotechnology | Chief Executive Officer | |
Sund Capital ApS
 Sund Capital ApS Financial ConglomeratesFinance Sund Capital ApS provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer | |
| The Cass Foundation | Director/Board Member | ||
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Fort Hill Cos. Llc | Director/Board Member | ||
Sanofi AB
 Sanofi AB Medical DistributorsDistribution Services Part of Sanofi, Sanofi AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company's description states that it is an international pharmaceutical company. | Medical Distributors | Corporate Officer/Principal | |
| Sorbonne Université | College/University | Undergraduate Degree | |
| Université de Montpellier | College/University | Doctorate Degree | |
Laboratoire Chauvin SAS
 Laboratoire Chauvin SAS Pharmaceuticals: OtherHealth Technology Part of Bausch Health Cos., Inc., Laboratoire Chauvin SAS is a French company that specializes in medicinal chemicals and botanical products. The company is based in Montpellier, France. The CEOs of the company are Eberhard Kühne, William Woodfield, Jean-Christophe Henry. | Pharmaceuticals: Other | General Counsel | |
| L'Université d'Angers | College/University | Doctorate Degree | |
Merck Serono SAS
 Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sanofi Aventis Participations SAS
 Sanofi Aventis Participations SAS Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis Participations SAS is a pharmaceutical company based in Paris, France. The French company manufactures pharmaceuticals. The CEO of the company is Mathias Thibault. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INFLARX N.V. | Biotechnology | Director/Board Member | |
| Jane Goddall Institute Belgium | Director/Board Member |
Statistiques
Internationale
| France | 29 |
| Etats-Unis | 8 |
| Royaume-Uni | 5 |
| Suède | 3 |
| Belgique | 3 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 4 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 71 |
| Chairman | 16 |
| Corporate Officer/Principal | 16 |
| Chief Executive Officer | 14 |
| Independent Dir/Board Member | 13 |
Relations les plus connectées
| Insiders | |
|---|---|
| Philippe Boucheron | 24 |
| Catherine Dunand | 23 |
| David Solomon | 22 |
| Thibaut Roulon | 18 |
| Charlotte Sibley | 13 |
| André Ulmann | 11 |
| Hege Hellstrom | 11 |
| Didier Laurens | 8 |
| Catherine Guittet | 7 |
| Nathalie Lemarié | 3 |
| Véronique Leblanc | 3 |
- Bourse
- Insiders
- Laurent Cassedannemr
- Connexions Sociétés
